If you have questions or to offer support, please contact the Pamela B. Katten Memorial Leukemia Research Foundation using our online form.
Pam Katten passed away in September 2002 at the age of 41 from Acute Myelogenous Leukemia (AML). Since 2003, the Pamela B. Katten Memorial Leukemia Research Foundation has worked to honor and remember Pam by raising more than $2,500,000 for leukemia research and provide patient assistance. Our primary beneficiary has been the Leukemia & Lymphoma Society (LLS), with funds going towards selected research projects.
For the past three years, the Pamela B. Katten Memorial Leukemia Research Foundation, as Team PamJam, participated at LLS’ Glenview Light the Night Walk. Thank you for your support and helping us to become one of the top fundraising teams in the state! From 2003-2014, the Foundation’s PamJam event was LLS’ Illinois Chapter’s largest third party fundraising event.
The Need For A Cure:
Blood cancers affect a growing number of Americans each year. Last year, more than 137,000 new cases of leukemia, lymphoma, Hodgkin’s disease and myeloma were diagnosed in the United States. An estimated 1,000,000 Americans are presently living with one of these cancers and over 60,000 people will die this year from one of these diseases. Leukemia is the number one cancer killer of children under the age of 14. In Illinois, an estimated 5,000 new patients will be diagnosed this year with a blood cancer.
About The Leukemia & Lymphoma Society (LLS):
The Leukemia & Lymphoma Society is the world’s largest voluntary health organization dedicated to curing leukemia, lymphoma Hodgkin’s disease and myeloma and improving the quality of life of patients and their families. LLS was founded in 1949 by the de Villiers family of New York after they lost their only child, Robert, to leukemia at the age of 16. Over the past 60 plus years, LLS has invested more than $750 million in promising scientists conducting cutting edge research aimed at discovering a sure for leukemia, lymphoma and related blood cancers.
In addition to research, the Society provides a wide range of patient services programs including financial aid, family support groups, peer to peer counseling, pediatric support programs, information and referral services and advocacy.
Over the past 60 years, LLS has gone from talking about leukemia to talking about cancer; from finding a cure for leukemia to finding a cure for cancer.
Since its founding, The Leukemia & Lymphoma Society has impacted the scientific community with discoveries in cancer genetics, immunology and cell biology. LLS helped to fund the discovery of chemotherapy, sequential chemo-radiation, antibody therapeutics, and bone marrow and stem cell transplantation. These new treatments, pioneered in blood cancer research, are now used for treating many other malignancies including breast, skin, lung, colon and pancreatic cancers. An investment in blood cancer research today will impact the greater cancer community.